WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update
Excerpt
The WHO treatment guidelines for drug-resistant tuberculosis (2016 update) contains policy recommendations on priority areas in the treatment of drug-resistant tuberculosis. The revision is in accordance with the WHO requirements for the formulation of evidence-informed policy.
The main novelties of the 2016 WHO guidelines are:
a shorter MDR-TB treatment regimen is recommended under specific conditions;
medicines used in the design of conventional MDR-TB treatment regimens are now reclassified to reflect updates in the evidence on their effectiveness and safety;
specific recommendations are made on the treatment of children with rifampicin-resistant or MDR-TB based on a first-ever individual patient data meta-analysis;
recommendations on the role of surgery in MDR-TB case management are included.
Copyright © World Health Organization 2016.
Source: PubMed